On NSE, the share gained up to 66.11% over issue price, rising to Rs 706. Earlier, share of Rossari Biotech made its debut at Rs 669.25 climbing 57.46% above issue price of Rs 425.
Rossari Biotech IPO: First post-Covid share sale a huge hit, subscribed 79 times
The initial public offering (IPO) of Mumbai-based speciality chemicals maker Rossari Biotech was subscribed over 79 times on the last day of bidding on July 15. The firm aimed to raise Rs 500 crore through the IPO. It received bids for 64,87,33,645 shares against the total issue size of 81,73,530 shares, NSE data show. Shares were available for bidding in a lot of 35 during the IPO.
Rossari Biotech IPO: How to check allotment status
The IPO was launched on July 13 and ended on July 15. It was launched after a lull of four months as COVID-19 affected sentiment on Dalal Street. On March 2, SBI Cards and Payment Services floated its IPO which saw weak response amid a volatile market.
Bids for the IPO were invited within price band of Rs 423 to Rs 425 per equity share. The company raised Rs 149 crore from anchor investors.
Stocks in news: Vodafone Idea, Larsen & Turbo, Rallis India, ICICI Securities
The IPO comprised fresh issue of shares to the tune of Rs 150 crore and sale of more than 1 crore equity shares by the company's promoters through offer-for-sale route.
Rossari Biotech is a specialty chemicals manufacturing firm with focus on home and personal care, performance chemicals, textile specialty chemicals and animal health and nutrition products. The firm has presence in 17 foreign countries including Vietnam, Bangladesh and Mauritius.
Its main product categories include; (a) Home, personal and performance chemicals, (b) textile specialty chemicals and (c) animal health and nutritional products.
Share Market LIVE: Sensex drops 50 points, Nifty at 11,135; Biocon, PNB Housing, Biocon Q1 results today